Evaluation of polymyxin B epsilometer test susceptibility to multidrug-resistant Gram-negative clinical isolates at a tertiary care center
Saudi Journal for Health Sciences · 2026-01 · 15 (1) · 36-40
DOI: 10.4103/sjhs.sjhs_5_26 ↗Kurz gefasst
Fachartikel in der Zeitschrift Saudi Journal for Health Sciences, online erschienen am 29.04.2026. Verfasst von Laveena D’Souza und 1 weiteren Autor:innen. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Multidrug-resistant (MDR) Gram-negative bacilli that release carbapenemase enzymes ensure that they are not affected by many beta-lactam antibiotics and carbapenems. The methodology of testing susceptibility to polymyxin B can pose a challenge in a clinical scenario.
Aims
To assess polymyxin B, E -test susceptibility against Gram-negative bacteria that are MDR and compare the results of it with broth micro dilution (BMD). Settings and Design: This prospective observational study was done at a tertiary care center laboratory for 1 year. Materials and Methods: Polymyxin B susceptibility against 74 Gram-negative clinical isolates were assessed using the E -test and BMD as per the Clinical Laboratory Standards Institute recommendations. Statistical Analysis: Descriptive statistics of frequency, percentage, median, and intra-quartile range were done. Kolmogorov–Smirnov test was performed to assess the normality of the numerical variables.
Results
The predominant organisms isolated were Klebsiella pneumoniae (55.4%) followed by Pseudomonas aeruginosa (21.6%), Acinetobacter baumanni complex (16.2%), Escherichia coli (4.1%), and Enterobacter cloacae (2.7%). The polymyxin B susceptibility ranges were much higher by E -test method when cross checked with BMD (97% as against 77%; with P < 0.0001). E -test however correlated poorly with BMD.
Conclusion
BMD testing proved to be a more reliable method in situations where the clinical response to infection was inadequate or compromised.
Zitieren
APA
D’Souza, L., & Kuruvilla, T. S. (2026). Evaluation of polymyxin B epsilometer test susceptibility to multidrug-resistant Gram-negative clinical isolates at a tertiary care center. Saudi Journal for Health Sciences, 15(1), 36-40. https://doi.org/10.4103/sjhs.sjhs_5_26
Vancouver
D’Souza L, Kuruvilla TS. Evaluation of polymyxin B epsilometer test susceptibility to multidrug-resistant Gram-negative clinical isolates at a tertiary care center. Saudi Journal for Health Sciences. 2026;15(1):36-40. doi:10.4103/sjhs.sjhs_5_26
BibTeX
@article{DSouza2026,
author = {D’Souza, Laveena and Kuruvilla, Thomas S.},
title = {Evaluation of polymyxin B epsilometer test susceptibility to multidrug-resistant Gram-negative clinical isolates at a tertiary care center},
journal = {Saudi Journal for Health Sciences},
year = {2026},
volume = {15},
number = {1},
pages = {36--40},
doi = {10.4103/sjhs.sjhs_5_26}
}
EUVIMED